Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 2/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | AKT2 | P31751 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3830948 | 0.88 | ALDH1A1 (0.41) | ALDH1A1HTR2ATAAR1HDAC8CHRNB2 | |
| SCHEMBL2402230 | 0.86 | ALDH1A1 (0.50) | ALDH1A1KCNH2HDAC8CHRNB2CHRNB4 | |
| SCHEMBL2468564 | 0.83 | ALDH1A1 (0.37) | ALDH1A1KCNH2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL9108807 | 0.83 | ALDH1A1 (0.43) | ALDH1A1KCNH2CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL3827820 | 0.82 | ALDH1A1 (0.42) | ALDH1A1KCNH2TAAR1CHRNB2CHRNB4 | |
| SCHEMBL5197837 | 0.82 | ALDH1A1 (0.46) | ALDH1A1KCNH2HDAC8CHRNB2CHRNB4 | |
| SCHEMBL2468949 | 0.81 | ALDH1A1 (0.38) | ALDH1A1KCNH2HDAC8CHRNB2CHRNB4 | |
| SCHEMBL3474955 | 0.80 | ALDH1A1 (0.44) | ALDH1A1KCNH2HDAC8CHRNB2CHRNB4 | |
| SCHEMBL5702994 | 0.80 | THRB (0.42) | ALDH1A1KCNH2HTR2ACHRNB2CHRNB4 | |
| SCHEMBL3626967 | 0.80 | ALDH1A1 (0.48) | ALDH1A1HTR2ATAAR1HDAC8MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1642931-B1 | EMULSION COMPOSITION OF MODIFIED POLYPROPYLENE | TONEN SEKIYUKAGAKU KK (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-20070004847-A1 | Emulsion composition of modified polypropylene | TONEN CHEMICAL CORPORATION (JP) | 2007-01-04 | — | — | US | disclosed |
| US-20060281859-A1 | Method for producing modified polyolefin solution | TONEN CHEMICAL CORPORATION (JP) | 2006-12-14 | — | — | US | disclosed |
| EP-1642931-A1 | EMULSION COMPOSITION OF MODIFIED POLYPROPYLENE | Tonen Chemical Corporation (JP) | 2006-04-05 | — | — | EP | disclosed |
| EP-1607415-A1 | METHOD FOR PRODUCING MODIFIED POLYOLEFIN SOLUTION | Tonen Chemical Corporation (JP) | 2005-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004847-A1 | Emulsion composition of modified polypropylene | POLD1, DDHD2, POP1 | ALDH1A1 3661/4885KCNH2 4673/4885HTR2A 1709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.